![](/img/cover-not-exists.png)
Current and future drugs targeting one class of innate immunity receptors: the Toll-like receptors
Francois RomagneVolume:
12
Year:
2007
Language:
english
Pages:
8
DOI:
10.1016/j.drudis.2006.11.007
File:
PDF, 677 KB
english, 2007